^
Association details:
| Biomarker: | HR positive + BRCA positive |
|---|---|
| Cancer: | HER2 Positive Breast Cancer |
| Drug: | Lynparza (olaparib) (PARP inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
[The Treatment of Olaparib for BRCA Positive-Metastatic Breast Cancer Patient]
Excerpt:
...she had liver metastasis that showed IDC, ER(+), PgR (+), HER2(-). In addition, BRCA positive was shown. Therefore, the patient received olaparib tablets(300 mg twice daily). After 2 months later, liver metastasis reduced dramatically.
